Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79825.060.0195%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Ultralife Corp

ULBINASDAQ
Trade with Public
Trade with Public
$6.13
0.030.49%
At close: Sep 4, 5:00 PM EST
$6.70
0.579.3%
After Hours: Aug 26, 7:33 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Ultralife Analyst Price Targets

Wall Street analyst price targets and consensus rating for Ultralife (ULBI).

Price Target Range — 3 Quarters

Analyst Consensus — 1 Analysts

1Buy
Consensus RatingBuy# Analysts1Avg. Consensus PT$14Upside to Avg. PT+109.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Nov 15, 2024BenchmarkJosh SullivanMaintainedBuy$14
Jun 27, 2024BenchmarkJosh SullivanPT RaiseBuy$13→$14
More with Benzinga EdgeGet Access

Analyst Ratings News

US Stocks Likely To Open Mixed After Disappointing Q1 Performance: 'April Does Better After A Weak Q1,' Says Expert

U.S. stock futures were swinging between gains and losses on Tuesday after a mixed session on Monday. Futures of major benchmark indices were mixed in premarket trading. President Donald Trump‘s “Liberation Day”, the term he’s used for April 2nd, the day of incoming reciprocal tariffs, preceded a drop in stock prices.
Rishabh Mishra

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $14 Price Target

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $14 price target.
Benzinga Newsdesk

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $14

Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $13 to $14.
Benzinga Newsdesk

PRO
Benchmark Maintains Buy on Ultralife, Raises Price Target to $13

Benchmark analyst Josh Sullivan maintains Ultralife (NASDAQ:ULBI) with a Buy and raises the price target from $12 to $13.
Benzinga Newsdesk

PRO
Benchmark Reiterates Buy on Ultralife, Maintains $12 Price Target

Benchmark analyst Josh Sullivan reiterates Ultralife (NASDAQ:ULBI) with a Buy and maintains $12 price target.
Benzinga Newsdesk

Benzinga's Top Ratings Upgrades, Downgrades For March 26, 2021

 
Benzinga Insights

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved